Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Margherita RiminiWonseok KangValentina BurgioMara PersanoTamoko AokiShigeo ShimoseToshifumi TadaTakashi KumadaTakuya ShoEleonora LaiCiro CelsaClaudia CampaniMatteo TonniniEmiliano TamburiniAtsushi HiraokaKoichi TakaguchiNaoshi NishidaHideki IwamotoEi ItobayashiKunihiko TsujiNaoya SakamotoToru IshikawaHidenori ToyodaMasatoshi KudoTakumi KawaguchiTakeshi HatanakaKazugiro NousoGoki SudaGiuseppe CabibboFabio MarraAngelo Della CorteFrancesca RattiFederica PedicaFrancesco De CobelliLuca AldrighettiMario ScartozziStefano CascinuAndrea Casadei-GardiniPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
The lenvatinib prognostic index confirms its prognostic value on an external cohort of hepatocellular carcinoma patients treated with Lenvatinib.
Keyphrases